TWST (Twist Bioscience) Buyback Yield % : 0.07 (As of Apr. 11, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Twist Bioscience Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Twist Bioscience's current buyback yield was 0.07%.

Twist Bioscience Buyback Yield % Historical Data

The historical data trend for Twist Bioscience's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twist Bioscience Buyback Yield % Chart

Twist Bioscience Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Buyback Yield %

Get a 7-Day Free Trial

-8.56

-5.91

-13.16

0.38

0.15

Twist Bioscience Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															0.27	0.31	0.18	0.15	0.06

Competitive Comparison of Twist Bioscience's Buyback Yield %

For the Diagnostics & Research subindustry, Twist Bioscience's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Twist Bioscience's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Twist Bioscience's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Twist Bioscience Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Twist Bioscience's Buyback Yield for the fiscal year that ended in Sep. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-3.975	+	0)	/	2660.06286
	=	0.15%

Twist Bioscience's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (-1.557	+	0)		/	2768.77554
	=	0.06%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Twist Bioscience Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Twist Bioscience's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Twist Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Twist Bioscience Corp (NAS:TWST) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

0ME:Germany

Address

681 Gateway Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.twistbioscience.com

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Executives

Dennis Cho	officer: See Remarks	C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080
Emily M. Leproust	director, officer: President & CEO	C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Paula Green	officer: VP of Human Resources	C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Robert F. Werner	officer: Chief Accounting Officer	2500 FABER PLACE, PALO ALTO CA 94303
Patrick John Finn	officer: VP of Sales and Marketing	C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Robert Chess	director
William Banyai	director, officer: Chief Operating Officer	C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Melissa A. Starovasnik	director	C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080
Jan Johannessen	director	5555 NE MOORE CT., HILLSBORO OR 97124
James M Thorburn	officer: Chief Financial Officer	C/O ZILOG INC, 532 RACE STREET, SAN JOSE CA 95126
Nicolas Barthelemy	director	1750 BELLA LAGUNA CT, ENCINITAS CA 92024
Patrick Weiss	officer: VP of Operations	C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Keith Crandell	director	8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631
Kevin Bruce Yankton	officer: Chief Accounting Officer	1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104
Mark Daniels	officer: Chief Compliance Officer & GC	C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158